This study, called GABS-DART, is looking at whether gabapentin (a medication sometimes used for pain) should be a standard part of pain control for patients having mastectomy (breast removal surgery) at Memorial Sloan Kettering Cancer Center. The study will compare how much pain medication (measured in morphine milligram equivalents or MMEs) is needed after surgery when gabapentin is removed from the pre-operative order set. You may be able to join if you are between 18 and 65 years old and are having a mastectomy at the Josie Robertson Surgical Center. The study plans to enroll 1896 participants, but its current status is unclear.

Study design

This is an interventional study that plans to enroll 1896 participants. It involves a modification to the pre-operative order set to remove gabapentin.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your need for pain medication will be measured for up to 46 months after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.